Vericel Total Assets from 2010 to 2024

VCEL Stock

USD 56.71 0.55 0.96%

Vericel Corp Total Assets yearly trend continues to be quite stable with very little volatility. Total Assets may rise above about 371.3 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1996-09-30

Previous Quarter

376.8 M

Current Value

390.4 M

Quarterly Volatility

95.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Vericel Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vericel Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.9 M, Interest Expense of 630 K or Total Revenue of 207.4 M, as well as many indicators such as Price To Sales Ratio of 8.15, Dividend Yield of 0.0 or PTB Ratio of 3.9. Vericel financial statements analysis is a perfect complement when working with Vericel Corp Valuation or Volatility modules.

Check out the analysis of Vericel Corp Correlation against competitors.

Latest Vericel Corp's Total Assets Growth Pattern

Below is the plot of the Total Assets of Vericel Corp Ord over the last few years. Total assets refers to the total amount of Vericel Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vericel Corp Ord books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Vericel Corp's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 353.66 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Vericel Total Assets Regression Statistics

	Arithmetic Mean	129,942,323
	Geometric Mean	65,956,383
	Coefficient Of Variation	99.23
	Mean Deviation	109,452,921
	Median	54,577,000
	Standard Deviation	128,945,054
	Sample Variance	16626.8T
	Range	363.6M
	R-Value	0.94
	Mean Square Error	2058.1T
	R-Squared	0.89
	Slope	27,125,386
	Total Sum of Squares	232775.6T

Vericel Total Assets History

	2024	371.3 M
	2023	353.7 M
	2022	273 M
	2021	243.7 M
	2020	205.6 M
	2019	153.2 M
	2018	118.7 M

Other Fundumenentals of Vericel Corp Ord

Intangibles To Total Assets

Vericel Corp Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.99	0.48	-0.62	0.92	0.98	0.95	0.99	0.91	0.76	0.92	0.96	0.44	0.83	0.96	-0.16	0.83	0.42	0.95	0.94	0.94	0.89
Total Stockholder Equity	0.99		0.37	-0.69	0.89	0.98	0.9	0.99	0.89	0.81	0.96	0.95	0.49	0.85	0.96	-0.18	0.88	0.42	0.95	0.96	0.91	0.86
Net Debt	0.48	0.37		0.19	0.4	0.44	0.66	0.39	0.56	0.3	0.21	0.51	-0.11	0.37	0.43	-0.1	0.22	0.1	0.42	0.37	0.47	0.47
Retained Earnings	-0.62	-0.69	0.19		-0.59	-0.7	-0.42	-0.66	-0.51	-0.51	-0.86	-0.58	-0.6	-0.65	-0.62	-0.11	-0.64	-0.52	-0.59	-0.6	-0.49	-0.49
Accounts Payable	0.92	0.89	0.4	-0.59		0.92	0.89	0.89	0.89	0.6	0.84	0.81	0.16	0.67	0.81	-0.11	0.65	0.38	0.82	0.8	0.92	0.73
Net Receivables	0.98	0.98	0.44	-0.7	0.92		0.92	0.98	0.9	0.76	0.95	0.93	0.46	0.86	0.93	-0.07	0.82	0.51	0.92	0.91	0.9	0.83
Total Liab	0.95	0.9	0.66	-0.42	0.89	0.92		0.9	0.88	0.61	0.79	0.93	0.29	0.75	0.87	-0.09	0.66	0.38	0.87	0.84	0.94	0.88
Total Current Assets	0.99	0.99	0.39	-0.66	0.89	0.98	0.9		0.89	0.83	0.95	0.93	0.49	0.88	0.96	-0.13	0.87	0.46	0.95	0.96	0.91	0.84
Short Term Debt	0.91	0.89	0.56	-0.51	0.89	0.9	0.88	0.89		0.69	0.82	0.8	0.26	0.76	0.86	-0.18	0.73	0.38	0.81	0.81	0.82	0.69
Short Term Investments	0.76	0.81	0.3	-0.51	0.6	0.76	0.61	0.83	0.69		0.78	0.72	0.46	0.81	0.82	-0.24	0.9	0.34	0.83	0.87	0.63	0.59
Common Stock	0.92	0.96	0.21	-0.86	0.84	0.95	0.79	0.95	0.82	0.78		0.88	0.6	0.88	0.91	-0.02	0.86	0.51	0.88	0.89	0.81	0.78
Property Plant Equipment	0.96	0.95	0.51	-0.58	0.81	0.93	0.93	0.93	0.8	0.72	0.88		0.5	0.79	0.93	-0.19	0.81	0.36	0.94	0.92	0.91	0.95
Current Deferred Revenue	0.44	0.49	-0.11	-0.6	0.16	0.46	0.29	0.49	0.26	0.46	0.6	0.5		0.62	0.44	0.07	0.67	0.4	0.44	0.47	0.2	0.51
Long Term Debt	0.83	0.85	0.37	-0.65	0.67	0.86	0.75	0.88	0.76	0.81	0.88	0.79	0.62		0.86	0.23	0.81	0.44	0.81	0.83	0.68	0.69
Net Tangible Assets	0.96	0.96	0.43	-0.62	0.81	0.93	0.87	0.96	0.86	0.82	0.91	0.93	0.44	0.86		-0.17	0.84	0.34	0.95	0.95	0.89	0.86
Long Term Debt Total	-0.16	-0.18	-0.1	-0.11	-0.11	-0.07	-0.09	-0.13	-0.18	-0.24	-0.02	-0.19	0.07	0.23	-0.17		-0.29	0.1	-0.22	-0.23	-0.17	-0.18
Intangible Assets	0.83	0.88	0.22	-0.64	0.65	0.82	0.66	0.87	0.73	0.9	0.86	0.81	0.67	0.81	0.84	-0.29		0.29	0.85	0.88	0.66	0.7
Short Long Term Debt	0.42	0.42	0.1	-0.52	0.38	0.51	0.38	0.46	0.38	0.34	0.51	0.36	0.4	0.44	0.34	0.1	0.29		0.37	0.38	0.31	0.31
Net Invested Capital	0.95	0.95	0.42	-0.59	0.82	0.92	0.87	0.95	0.81	0.83	0.88	0.94	0.44	0.81	0.95	-0.22	0.85	0.37		0.99	0.93	0.88
Net Working Capital	0.94	0.96	0.37	-0.6	0.8	0.91	0.84	0.96	0.81	0.87	0.89	0.92	0.47	0.83	0.95	-0.23	0.88	0.38	0.99		0.9	0.85
Capital Stock	0.94	0.91	0.47	-0.49	0.92	0.9	0.94	0.91	0.82	0.63	0.81	0.91	0.2	0.68	0.89	-0.17	0.66	0.31	0.93	0.9		0.87
Long Term Investments	0.89	0.86	0.47	-0.49	0.73	0.83	0.88	0.84	0.69	0.59	0.78	0.95	0.51	0.69	0.86	-0.18	0.7	0.31	0.88	0.85	0.87

Click cells to compare fundamentals

About Vericel Corp Financial Statements

Vericel Corp investors utilize fundamental indicators, such as Total Assets, to predict how Vericel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	353.7 M	371.3 M
Intangibles To Total Assets	0.02	0.02

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Vericel Corp Correlation against competitors.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

0.08

Revenue Per Share

4.685

Quarterly Revenue Growth

0.27

Return On Assets

(0)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Total Assets from 2010 to 2024

Latest Vericel Corp's Total Assets Growth Pattern

Vericel Total Assets Regression Statistics

Vericel Total Assets History

Other Fundumenentals of Vericel Corp Ord

Vericel Corp Total Assets component correlations

About Vericel Corp Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY